/Investor DB

Omnes Capital — 2013 Investments

4 investments dated 2013 · listed companies and verified rows first · show all

Complixcomplix.comJun 2013

Complix develops therapeutic biologics based on Alphabody technology targeting viral diseases, oncology, and autoimmune conditions.

AI & Machine LearningBiotechDeep TechMedical Devices

Co-investorsPMVAndera PartnersVesalius Biocapital PartnersGimv

Opsonaopsona.comSeries C · Oct 2013 · $4M

Co-investorsFountain Healthcare Partners

Pixium Visionpixium-vision.comNov 2013

Pixium Vision SA developed the PRIMA System, an implantable device for treating late-stage macular degeneration, and ran clinical trials in Europe.

BiotechHealthtechMedical Devices

Co-investorsAgoranovSofinnova PartnersAbingworthBpifrance

Tissiumtissium.com𝕏Series A · Dec 2013 · $11M

TISSIUM develops biomorphic polymer technology, including proprietary polymers, activation technologies, and delivery devices, to reconstruct damaged tissue and restore its function across multiple therapeutic areas.

BiotechDeep TechMedical DevicesNew Materials

Christophe Bancel(Co-founder & CEO)inMaria Pereira(Co-inventor of the technology; leads the Innovation Hub)in

Co-investorsCapDecisif ManagementCathay HealthKaristaSofinnova PartnersCathay InnovationEuropean Investment Bank

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.